Consensus statement on the future of mannan-binding lectin (MBL)-replacement therapy.
Kilpatrick
D C
DC
Scottish National Blood Transfusion Service National Science Laboratory, Ellen's Glen Road, Edinburgh EH17 7QT, UK. dave.kilpatrick@snbts.csa.scot.nhs.uk
D018849:Controlled Clinical Trials as Topic; D006801:Humans; D037601:Mannose-Binding Lectin / Q000627:therapeutic use*; D013812:Therapeutics / Q000379:methods / Q000639:trends
D037601:Mannose-Binding Lectin